Clinical Trial Update: Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

This clinical trial explores combining apatinib with the XELOX chemotherapy regimen (capecitabine plus oxaliplatin) to treat colorectal cancer in a Phase 2 stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Apatinib (apatinib)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Shoucheng Ma | Conditions: Colorectal Neoplasms | Phase 2 | Status: UNKNOWN